Biosimilar
New Biosimilar Era | FDA’s Biggest Shift
Chief Pharmacist
FDA has delivered the most consequential policy change in two decades, a shift that fundamentally transforms how our industry will ...
Basic Difference Between Biosimilar and Bioequivalence
Chief Pharmacist
A “Biosimilar” refers to a biologic drug that is highly similar to an already approved biologic (“reference product”), meaning it ...
Biosimilar Drugs
Chief Pharmacist
Biosimilars are highly similar to an already approved reference biologic, with no clinically meaningful differences in terms of safety, purity, ...